Literature DB >> 21865651

Parkin reinvents itself to regulate fatty acid metabolism by tagging CD36.

Nada A Abumrad1, Darren J Moore.   

Abstract

Parkinson disease (PD) is a relatively common neurodegenerative disorder characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra. About 5%-10% of PD cases are inherited. Mutations in the Parkin gene, which encodes a protein that can function as an E3 ubiquitin ligase, are a common cause of familial PD. Such mutations act in a loss-of-function manner and impair the ability of the encoded protein to mediate substrate ubiquitination, although the subsequent molecular pathway that precipitates neuronal degeneration is poorly defined. In this issue of the JCI, Kim and colleagues describe painstaking evidence using a number of dissecting approaches in intact animals and cultured cells to functionally link Parkin and the class B scavenger receptor CD36, suggesting a novel and complex connection between PD and fatty acid metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865651      PMCID: PMC3163977          DOI: 10.1172/JCI59219

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms.

Authors:  Arunima Ghosh; Gurunathan Murugesan; Kan Chen; Li Zhang; Qing Wang; Maria Febbraio; Rita Marie Anselmo; Kandice Marchant; John Barnard; Roy L Silverstein
Journal:  Blood       Date:  2011-04-08       Impact factor: 22.113

2.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

3.  Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.

Authors:  Kye-Young Kim; Mark V Stevens; M Hasina Akter; Sarah E Rusk; Robert J Huang; Alexandra Cohen; Audrey Noguchi; Danielle Springer; Alexander V Bocharov; Tomas L Eggerman; Der-Fen Suen; Richard J Youle; Marcelo Amar; Alan T Remaley; Michael N Sack
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

4.  Parkin: a multifaceted ubiquitin ligase.

Authors:  D J Moore
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

5.  Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.

Authors:  Latisha Love-Gregory; Richard Sherva; Timothy Schappe; Jian-Shen Qi; Jennifer McCrea; Samuel Klein; Margery A Connelly; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2010-10-08       Impact factor: 6.150

6.  Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.

Authors:  Jessica C Greene; Alexander J Whitworth; Isabella Kuo; Laurie A Andrews; Mel B Feany; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

7.  Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy.

Authors:  Nickie C Chan; Anna M Salazar; Anh H Pham; Michael J Sweredoski; Natalie J Kolawa; Robert L J Graham; Sonja Hess; David C Chan
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

Review 8.  Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide.

Authors:  Akhlaq A Farooqui; Lloyd A Horrocks; Tahira Farooqui
Journal:  J Neurosci Res       Date:  2007-07       Impact factor: 4.164

9.  Dietary fat intake and risk of Parkinson's disease: a case-control study in Japan.

Authors:  Yoshihiro Miyake; Satoshi Sasaki; Keiko Tanaka; Wakaba Fukushima; Chikako Kiyohara; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  J Neurol Sci       Date:  2009-10-12       Impact factor: 3.181

Review 10.  Mendelian forms of Parkinson's disease.

Authors:  Thomas Gasser
Journal:  Biochim Biophys Acta       Date:  2009-01-06
View more
  7 in total

Review 1.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

Review 2.  Parkin in the regulation of fat uptake and mitochondrial biology: emerging links in the pathophysiology of Parkinson's disease.

Authors:  Kye-Young Kim; Michael N Sack
Journal:  Curr Opin Lipidol       Date:  2012-06       Impact factor: 4.776

3.  Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation.

Authors:  Komudi Singh; Kim Han; Sharada Tilve; Kaiyuan Wu; Herbert M Geller; Michael N Sack
Journal:  Glia       Date:  2018-10-30       Impact factor: 7.452

4.  Lipidomic Alterations in the Mitochondria of Aged Parkin Null Mice Relevant to Autophagy.

Authors:  Angel Gaudioso; Patricia Garcia-Rozas; Maria Jose Casarejos; Oscar Pastor; Jose Antonio Rodriguez-Navarro
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

Review 5.  CD36 tango in cancer: signaling pathways and functions.

Authors:  Jingchun Wang; Yongsheng Li
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

Review 6.  The role of CD36 in cardiovascular disease.

Authors:  Hongyang Shu; Yizhong Peng; Weijian Hang; Jiali Nie; Ning Zhou; Dao Wen Wang
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

7.  Inhibition of USP14 suppresses the formation of foam cell by promoting CD36 degradation.

Authors:  Fangcheng Zhang; Xiaohong Xia; Renjie Chai; Ruqin Xu; Qiong Xu; Mingke Liu; Xuke Chen; Bin Liu; Shiming Liu; Ningning Liu
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.